SIRAGUSA, Giuseppe
SIRAGUSA, Giuseppe
Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche
Extracellular vesicles as a novel immunotherapeutic strategy in hashimoto’s thyroiditis: advances in targeted delivery technologies
2025-05-01 Laura Tomasello, Valentina Guarnotta, Giuseppe Siragusa,Mattia Biondo, Giorgio Arnaldi, Carla giordano, Giuseppe Pizzolanti
In silico lead optimization and synthesis of a new series of thieno[3,2-c]quinoline with antiproliferative activity on RET-dependent medullary thyroid cancer cells
2023-12-11 Gabriele La Monica; Giuseppe Pizzolanti; Concetta Baiamonte; Alessia Bono; Federica Alamia; Giuseppe Siragusa; Francesco Mingoia; Antonino Lauria; Annamaria Martorana
Optimized imidazole-thieno[3,2-c]quinolines: promising antiproliferative compounds for thyroid and NCI60 cancer cells
2024-11-01 Gabriele La Monica, Alessia Bono, Federica Alamia, Antonino Lauria, Giuseppe Pizzolanti, Giuseppe Siragusa, Concetta Baiamonte, Annamaria Martorana
POLYPHENOLS AS A POTENTIAL STRATEGY IN OVERCOMING THERAPY RESISTANCE IN ANAPLASTIC THYROID CANCER THROUGH THE SOX2-SOX17 MOLECULAR SWITCH
2025-01-01 Fabiola VAGLICA, Laura TOMASELLO, Mattia BIONDO, Giuseppe SIRAGUSA, Giorgio ARNALDI, Giuseppe PIZZOLANTI
SOX2/SOX17 Molecular Switching by Polyphenols to Promote Thyroid Differentiation in 2D and 3D Models of Anaplastic Thyroid Cancer
2025-12-01 Vaglica, F.; Biondo, M.; Siragusa, G.; Arnaldi, G.; Guarnotta, V.; Pizzolanti, G.; Tomasello, L.
Survivin (BIRC5): Implications in cancer therapy
2024-06-05 Siragusa, Giuseppe; Tomasello, Laura; Giordano, Carla; Pizzolanti, Giuseppe